- Home
- QS vs BRKR Comparison
QS vs BRKR Comparison
Compare QS & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QS | BRKR |
|---|---|---|
| Founded | 2010 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 7.0B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | QS | BRKR |
|---|---|---|
| Price | $11.83 | $45.15 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 8 | 12 |
| Target Price | $9.06 | ★ $46.45 |
| AVG Volume (30 Days) | ★ 17.6M | 2.3M |
| Earning Date | 10-22-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,438,900,000.00 |
| Revenue This Year | N/A | $3.61 |
| Revenue Next Year | N/A | $1.23 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.10 |
| 52 Week Low | $3.40 | $28.53 |
| 52 Week High | $19.07 | $64.64 |
Technical Indicators
Market Signals| Indicator | QS | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 40.55 | 51.48 |
| Support Level | $11.57 | $44.96 |
| Resistance Level | $13.00 | $47.88 |
| Average True Range (ATR) | 0.64 | 1.82 |
| MACD | 0.07 | -0.55 |
| Stochastic Oscillator | 27.70 | 2.89 |
Price Performance
Historical ComparisonAbout QS QuantumScape Corporation
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional anodes.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.